Developer docs
API playgroundTry for free, no card

Search company profiles

Metatissue

Full company profile

uuid000skxv

Namestring
Metatissue
Websiteurl
metatissue.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Metatissue is a privately held Portuguese biotechnology company founded in 2018 and headquartered in Ílhavo, Portugal. According to its firmographic record, the company focuses on the design and production of human-based products for cell culture and tissue engineering, serving the life sciences research and biomedical markets. The company's intended customer base implicitly spans academic research laboratories, pharmaceutical R&D, and regenerative medicine/biomaterials workflows, though no specific customer segments, logos, or contracted relationships have been disclosed.

The company operates at micro-scale, reporting 1-10 employees, and remains privately held with no public-market listing. Its commercial mechanics are not characterized in the source material: no pricing model, distribution channels, marketing channels, customer mix, or product catalog was disclosed. The company's primary web property (metatissue.com) was inaccessible during data collection, returning only a loader/verification page rather than substantive content. No leadership team, contacts, social profiles, or operating geographies were documented. The sole resolvable source identifier confirms only that the entity is in operating status.

No specific products, services, patents, certifications, funding history, partnerships, or awards appear in the available data. As a result, the technology stack, manufacturing process, proprietary know-how, and revenue model cannot be characterized with specificity. The cell culture and tissue engineering positioning suggests adjacency to the broader human-cell-derived reagents, 3D cell culture scaffolds, and tissue model markets, but this remains an inference based on the company description rather than evidence-backed fact.

Short descriptiontext

Metatissue is a privately held Portuguese biotechnology company, founded in 2018 and headquartered in Ílhavo, that designs and produces human-based products for cell culture and tissue engineering. The 1-10 employee firm serves life sciences and biomedical research customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersÍlhavo, Portugal
HQ citystring
Ílhavo
HQ countrystring
Portugal
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
tissue engineering, cell culture products, human biomaterials, regenerative medicine, biotechnology products
Industry1 code
PRIMARYHLAMANAI
Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Tissue Engineering & Cell Culture Products
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Metatissue is a biotechnology company focusing on the design and production of human-based products for cell culture and tissue engineering. The company manufactures biological inputs intended for use in laboratory cell culture workflows and tissue engineering applications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available.

Product and service1 record
1Human-based products for cell culture and tissue engineering
No data
Peers10 records
TypeDirect peer
Description

Organogenesis is a commercial-stage regenerative medicine company developing human-derived wound care and surgical tissue products. Comparable to Metatissue in using human-based biological substrates for tissue repair and engineering applications.

TypeBroad incumbent
Description

Lonza is a global contract development and manufacturing organization with a large cell and gene therapy services and products portfolio. Comparable to Metatissue at the category level as a supplier of cell culture media and bioprocess inputs used in tissue engineering, though operating at vastly larger scale and breadth.

TypeDirect peer
Description

CellGenix develops and manufactures GMP-grade raw materials and cell culture media for cell and gene therapy manufacturing. Overlaps with Metatissue in supplying human-relevant cell culture consumables to tissue engineering and advanced therapy developers.

TypeDirect peer
Description

PromoCell GmbH manufactures primary human cells, media, and cell culture reagents for research and cell therapy applications. Directly comparable to Metatissue as a supplier of human-based cell culture products used in tissue engineering and regenerative medicine workflows.

TypeBroad incumbent
Description

Gibco/Thermo Fisher is the dominant supplier of cell culture media, sera, and reagents used across regenerative medicine and tissue engineering. Comparable to Metatissue at the category level, though operating as a global incumbent rather than a focused human-derived specialty player.

6Corning Life Sciences
TypeBroad incumbent
Description

Corning supplies cell culture vessels, extracellular matrices (e.g., Matrigel-equivalent offerings), and media used in tissue engineering workflows. Comparable to Metatissue as a broad incumbent in cell culture consumables, though with a much wider product portfolio.

TypeEmerging player
Description

MatTek develops human tissue models and cell culture systems used in research and toxicology testing. Comparable to Metatissue as a developer of human-based tissue and cell culture products, with overlapping end users in academic and translational research.

8TissueTech
TypeDirect peer
Description

TissueTech develops and commercializes human birth tissue-derived products for wound healing and ocular surface regenerative applications. Directly comparable to Metatissue in leveraging human-derived biological materials for tissue engineering and regenerative medicine.

TypeDirect peer
Description

STEMCELL Technologies is a major developer of specialty cell culture media, separation products, and instruments for stem cell research and regenerative medicine. Comparable to Metatissue as a provider of cell culture inputs used in tissue engineering pipelines.

10Merck KGaA (Sigma-Aldrich / BioReliance)
TypeBroad incumbent
Description

Merck's life science division supplies cell culture media, raw materials, and bioprocess services for cell and gene therapy manufacturing. Comparable to Metatissue as a supplier of inputs for tissue engineering and cell therapy workflows at much greater scale.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Metatissue

Tissue Engineering & Cell Culture Productsmetatissue.com

Metatissue is a privately held Portuguese biotechnology company, founded in 2018 and headquartered in Ílhavo, that designs and produces human-based products for cell culture and tissue engineering. The 1-10 employee firm serves life sciences and biomedical research customers.

What Metatissue does

Metatissue is a privately held Portuguese biotechnology company founded in 2018 and headquartered in Ílhavo, Portugal. According to its firmographic record, the company focuses on the design and production of human-based products for cell culture and tissue engineering, serving the life sciences research and biomedical markets. The company's intended customer base implicitly spans academic research laboratories, pharmaceutical R&D, and regenerative medicine/biomaterials workflows, though no specific customer segments, logos, or contracted relationships have been disclosed.

The company operates at micro-scale, reporting 1-10 employees, and remains privately held with no public-market listing. Its commercial mechanics are not characterized in the source material: no pricing model, distribution channels, marketing channels, customer mix, or product catalog was disclosed. The company's primary web property (metatissue.com) was inaccessible during data collection, returning only a loader/verification page rather than substantive content. No leadership team, contacts, social profiles, or operating geographies were documented. The sole resolvable source identifier confirms only that the entity is in operating status.

No specific products, services, patents, certifications, funding history, partnerships, or awards appear in the available data. As a result, the technology stack, manufacturing process, proprietary know-how, and revenue model cannot be characterized with specificity. The cell culture and tissue engineering positioning suggests adjacency to the broader human-cell-derived reagents, 3D cell culture scaffolds, and tissue model markets, but this remains an inference based on the company description rather than evidence-backed fact.

Metatissue firmographics

Firmographics
Name
Metatissue
Website
https://metatissue.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Metatissue is a privately held Portuguese biotechnology company, founded in 2018 and headquartered in Ílhavo, that designs and produces human-based products for cell culture and tissue engineering. The 1-10 employee firm serves life sciences and biomedical research customers.
Ownership category
akta.pro rank

Metatissue industry classification

Industry
Product category
Tissue Engineering & Cell Culture Products
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMANAI
Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing)
Healthcare & Life Sciences/Veterinary & Animal Health/Regenerative Medicine for Animals

Keywords

  • Tissue engineering
  • Cell culture products
  • Human biomaterials
  • Regenerative medicine
  • Biotechnology products

Where Metatissue is headquartered

Location

Headquarters

HQ city
Ílhavo
HQ country
Portugal
HQ region
Europe

Markets served

Metatissue business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain

Metatissue product offering

Product offering

Core offering

Metatissue is a biotechnology company focusing on the design and production of human-based products for cell culture and tissue engineering. The company manufactures biological inputs intended for use in laboratory cell culture workflows and tissue engineering applications.

Product overview

No product information available.

Differentiator

Problem solved

Functional benefit

Products and services

  • Human-based products for cell culture and tissue engineering

Companies that use Metatissue

Customer profile

Ideal customer profiles1 record

Metatissue technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Metatissue competitors and assessment

Company assessment

Direct peers

  • Organogenesis Holdings: Organogenesis is a commercial-stage regenerative medicine company developing human-derived wound care and surgical tissue products. Comparable to Metatissue in using human-based biological substrates for tissue repair and engineering applications.
  • CellGenix: CellGenix develops and manufactures GMP-grade raw materials and cell culture media for cell and gene therapy manufacturing. Overlaps with Metatissue in supplying human-relevant cell culture consumables to tissue engineering and advanced therapy developers.
  • PromoCell: PromoCell GmbH manufactures primary human cells, media, and cell culture reagents for research and cell therapy applications. Directly comparable to Metatissue as a supplier of human-based cell culture products used in tissue engineering and regenerative medicine workflows.
  • TissueTech: TissueTech develops and commercializes human birth tissue-derived products for wound healing and ocular surface regenerative applications. Directly comparable to Metatissue in leveraging human-derived biological materials for tissue engineering and regenerative medicine.
  • Stemcell Technologies: STEMCELL Technologies is a major developer of specialty cell culture media, separation products, and instruments for stem cell research and regenerative medicine. Comparable to Metatissue as a provider of cell culture inputs used in tissue engineering pipelines.

Broad incumbents

  • Lonza Group: Lonza is a global contract development and manufacturing organization with a large cell and gene therapy services and products portfolio. Comparable to Metatissue at the category level as a supplier of cell culture media and bioprocess inputs used in tissue engineering, though operating at vastly larger scale and breadth.
  • Thermo Fisher Scientific (Gibco): Gibco/Thermo Fisher is the dominant supplier of cell culture media, sera, and reagents used across regenerative medicine and tissue engineering. Comparable to Metatissue at the category level, though operating as a global incumbent rather than a focused human-derived specialty player.
  • Corning Life Sciences: Corning supplies cell culture vessels, extracellular matrices (e.g., Matrigel-equivalent offerings), and media used in tissue engineering workflows. Comparable to Metatissue as a broad incumbent in cell culture consumables, though with a much wider product portfolio.
  • Merck KGaA (Sigma-Aldrich / BioReliance): Merck's life science division supplies cell culture media, raw materials, and bioprocess services for cell and gene therapy manufacturing. Comparable to Metatissue as a supplier of inputs for tissue engineering and cell therapy workflows at much greater scale.

Emerging players

  • MatTek Life Sciences: MatTek develops human tissue models and cell culture systems used in research and toxicology testing. Comparable to Metatissue as a developer of human-based tissue and cell culture products, with overlapping end users in academic and translational research.

Market position

Strengths3 records

Weaknesses4 records

Key risks5 records

Key highlights4 records

Customer concentration

Metatissue social profiles

Digital presence

Metatissue financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Metatissue leadership team

Management profile

Number of profiles

Metatissue funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Metatissue M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metatissue

What does Metatissue do?

Metatissue is a biotechnology company focusing on the design and production of human-based products for cell culture and tissue engineering. The company manufactures biological inputs intended for use in laboratory cell culture workflows and tissue engineering applications.

Is Metatissue a public or private company?

Metatissue is a private company. It is classified as unknown and is currently operating.

When was Metatissue founded?

Metatissue was founded in 2018. It employs 11 to 50 people.

Where is Metatissue based?

Metatissue is headquartered in Ílhavo, Portugal, in the Europe region.

Who are Metatissue's main competitors?

Direct peers on record are Organogenesis Holdings, CellGenix, PromoCell, TissueTech and Stemcell Technologies. Broad incumbents are Lonza Group, Thermo Fisher Scientific (Gibco), Corning Life Sciences and Merck KGaA (Sigma-Aldrich / BioReliance). MatTek Life Sciences is listed as an emerging player.

Does Metatissue have an API?

No public API is recorded for Metatissue.

What industry is Metatissue in?

Metatissue's product category is Tissue Engineering & Cell Culture Products. Its primary akta.pro industry code is HLAMANAI, Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales